Cancer drugs are always popular biotech investments, but autoimmune disease also figures prominently in the startup ...

This week, Congress reached a bipartisan healthcare deal as part of a larger $1.2 trillion spending bill, combining funding ...

President Donald Trump unveiled the Great Healthcare Plan to lower drug costs and insurance premiums, but healthcare ...

As OpenAI and Anthropic move deeper into healthcare, experts say AI chatbots are becoming the new front door to medicine. This shift is shaking things up for some health tech startups, redefining the ...

About 31,000 Kaiser Permanente healthcare workers plan to launch an open-ended strike over staffing shortages, wages and care access issues — potentially affecting dozens of hospitals and hundreds of ...

During two House hearings, health insurance CEOs were questioned on rising healthcare costs, vertical integration and prior authorization.

It’s not often that a pharmaceutical executive discusses a competitor’s success. Alkermes Chief Operating Officer Blair Jackson not only talks about it openly, he cheers it. Alkermes’s scope in ...

The healthcare AI world will likely undergo another year of rapid transformation in 2026, colored by fast-moving experimentation and adoption, according to a report published this week by Bessemer ...

Bristol Myers Squibb hasn’t had much luck with its efforts to develop cancer treatments called T cell engagers. But the pharmaceutical company isn’t done pursuing this type of targeted cancer therapy, ...